Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix and FOLFIRI or FOLFOX in First Line (VALIDATE)
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
A safety and efficacy study of first line therapy with Vectibix in combination with FOLFIRI or FOLFOX to validate a prognostic score in adult patients with RAS wild-type metastatic colorectal cancer in a real world setting (VALIDATE)
创建时间：
2017-01-15
